{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:10:28Z","timestamp":1767849028724,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T00:00:00Z","timestamp":1479427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.bjid.2016.10.003","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T11:15:33Z","timestamp":1480418133000},"page":"63-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine: a Phase III, open-label study of adults in Brazil"],"prefix":"10.1016","volume":"21","author":[{"given":"Cristiano A.F.","family":"Zerbini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Ribeiro dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Jose Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti","family":"Soni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varsha K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Opokua","family":"Ofori-Anyinam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2016.10.003_bib0170","unstructured":"United States Centers for Disease Control and Prevention. http:\/\/www.cdc.gov\/flu\/weekly\/pastreports.htm. Past weekly surveillance reports."},{"issue":"Suppl 1","key":"10.1016\/j.bjid.2016.10.003_bib0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/irv.12319","article-title":"Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study","volume":"9","author":"Caini","year":"2015","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.bjid.2016.10.003_bib0180","series-title":"Options for the control of influenza. Cape Town","first-page":"382","article-title":"Mismatch between vaccine strains and circulating influenza B viruses in different regions of Brazil: 2001\u20132013","author":"Oliveira","year":"2013"},{"key":"10.1016\/j.bjid.2016.10.003_bib0185","series-title":"Options for the control of influenza. Cape Town","first-page":"599","article-title":"Influenza virus surveillance conducted by the Institute Adolfo Lutz, S\u00e3o Paulo, SP, Brazil: 2013 influenza season","author":"Paiva","year":"2013"},{"key":"10.1016\/j.bjid.2016.10.003_bib0190","series-title":"Options for the control of influenza. Cape Town","first-page":"637","article-title":"Influenza B circulation during twelve influenza seasons (2001\u20132013) in a tertiary hospital in Sao Paulo, Brazil","author":"Perosa","year":"2013"},{"key":"10.1016\/j.bjid.2016.10.003_bib0195","unstructured":"World Health Organization. Influenza, FluNet. http:\/\/www.who.int\/influenza\/gisrs_laboratory\/flunet\/en\/."},{"key":"10.1016\/j.bjid.2016.10.003_bib0200","article-title":"Patterns of influenza B circulation in Brazil and its relevance to seasonal vaccine composition","author":"Barros","year":"2015","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2016.10.003_bib0205","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.vaccine.2011.12.098","article-title":"Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine","volume":"30","author":"Reed","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2016.10.003_bib0210","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/cid\/ciu664","article-title":"Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999\u20132012","volume":"59","author":"Heikkinen","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2016.10.003_bib0215","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1471-2334-13-224","article-title":"Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults","volume":"13","author":"Beran","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bjid.2016.10.003_bib0220","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/INF.0b013e31825687b0","article-title":"Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children","volume":"31","author":"Block","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bjid.2016.10.003_bib0225","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.1016\/j.vaccine.2011.09.109","article-title":"A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults","volume":"29","author":"Block","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2016.10.003_bib0230","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.vaccine.2015.03.065","article-title":"Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: a randomized, controlled, phase III trial","volume":"33","author":"Cadorna-Carlos","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2016.10.003_bib0235","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/infdis\/jit091","article-title":"A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3\u201317 years","volume":"207","author":"Domachowske","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bjid.2016.10.003_bib0240","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.vaccine.2015.01.025","article-title":"Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults","volume":"33","author":"Gorse","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2016.10.003_bib0245","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.vaccine.2012.11.074","article-title":"Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults","volume":"31","author":"Greenberg","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2016.10.003_bib0250","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/1471-2334-13-343","article-title":"Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged \u226518 years","volume":"13","author":"Kieninger","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bjid.2016.10.003_bib0255","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1016\/j.vaccine.2013.08.069","article-title":"Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults","volume":"31","author":"Pepin","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2016.10.003_bib0260","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/INF.0000000000000463","article-title":"Immunogenicity and safety of inactivated quadrivalent and trivalent influenza vaccines in children 18\u201347 months of age","volume":"33","author":"Rodriguez Weber","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bjid.2016.10.003_bib0265","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.vaccine.2014.01.022","article-title":"Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged \u226518 years: a phase III, randomized trial","volume":"32","author":"Tinoco","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2016.10.003_bib0270","series-title":"Guideline on influenza vaccines. Non-clinical and clinical module","author":"European Medicines Agency","year":"2014"},{"key":"10.1016\/j.bjid.2016.10.003_bib0275","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/00044011-200222110-00004","article-title":"Ten years of experience with the trivalent split-influenza vaccine, Fluarix\u2122","volume":"22","author":"Hehme","year":"2002","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.bjid.2016.10.003_bib0280","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0264-410X(94)90241-0","article-title":"Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial","volume":"12","author":"Govaert","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2016.10.003_bib0285","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000110579","article-title":"Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers","volume":"53","author":"Iorio","year":"2007","journal-title":"Gerontology"},{"key":"10.1016\/j.bjid.2016.10.003_bib0290","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1471-2334-14-133","article-title":"A historically-controlled Phase III study in adults to characterize the acceptability of a process change for manufacturing inactivated quadrivalent influenza vaccine","volume":"14","author":"Jain","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bjid.2016.10.003_bib0295","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/jmv.20801","article-title":"Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years","volume":"79","author":"Nabeshima","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/j.bjid.2016.10.003_bib0300","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4161\/hv.1.6.2376","article-title":"Rapid licensure of a new, inactivated influenza vaccine in the United States","volume":"1","author":"Treanor","year":"2005","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.bjid.2016.10.003_bib0305","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.vaccine.2015.11.058","article-title":"The confounded effects of age and exposure history in response to influenza vaccination","volume":"34","author":"Mosterin Hopping","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2016.10.003_bib0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2016.03.048","article-title":"Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013\u2013May 31, 2015","author":"Haber","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2016.10.003_bib0315","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1016\/j.vaccine.2007.07.027","article-title":"Influenza vaccine: the challenge of antigenic drift","volume":"25","author":"Carrat","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2016.10.003_bib0320","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4161\/hv.8.1.17623","article-title":"The rationale for quadrivalent influenza vaccines","volume":"8","author":"Ambrose","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.bjid.2016.10.003_bib0325","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/irv.12036","article-title":"Burden of influenza in Latin America and the Caribbean: a systematic review and meta-analysis","volume":"7","author":"Savy","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.bjid.2016.10.003_bib0330","doi-asserted-by":"crossref","first-page":"A578","DOI":"10.1016\/j.jval.2015.09.1927","article-title":"Public health and economic impact of a quadrivalent influenza vaccine in comparison to the trivalent influenza vaccine in Brazil over the period of 2010\u20132013","volume":"18","author":"Bricks","year":"2015","journal-title":"Value Health"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867016305487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867016305487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T05:26:09Z","timestamp":1536211569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867016305487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1413867016305487"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2016.10.003","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine: a Phase III, open-label study of adults in Brazil","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2016.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}